A carregar...
Targeting B cells in treatment of autoimmunity
B cells have emerged as effective targets for therapeutic intervention in autoimmunities in which the ultimate effectors are antibodies, as well as those in which T cells are primary drivers of inflammation. Proof of this principle has come primarily from studies of the efficacy of Rituximab, an ant...
Na minha lista:
| Publicado no: | Curr Opin Immunol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5127449/ https://ncbi.nlm.nih.gov/pubmed/27718447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.coi.2016.09.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|